ImmunoScape Inks Licensing Deal with Pure MHC to Advance Development of Novel TCR-Based Therapies
ImmunoScape will utilize Pure MHC’s library of T cell antigens specific to tumor cells to accelerate identification of novel T cell receptors using its Deep Immunomics platform